Axe Compute

Axe Compute Equity Ratio

The Equity Ratio of Axe Compute (AGPU) as of Oct 30, 2026 is 90.22 %. In the previous year, Equity Ratio was -4.07 % — a change of -2,314.26% (higher).

Equity Ratio

90.22 %

YoY

-2,314.26%

Last updated:

Equity Ratio of Axe Compute is 2025 90.22 % . Equity Ratio of Axe Compute was 2024 -4.07 % . It decreases by -2,314.26% higher compared to the previous year.

The Axe Compute Equity Ratio history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity Ratio
Date
Equity Ratio
Jan 1, 2018
1.44 USD
Jan 1, 2019
50.19 USD
Jan 1, 2020
20.23 USD
Jan 1, 2021
91.99 USD
Jan 1, 2022
84.58 USD
Jan 1, 2023
57.37 USD
Jan 1, 2024
-4.07 USD
Jan 1, 2025
90.22 USD
The Axe Compute Equity Ratio history
YEAREquity RatioYoY
90.22 %-2,314.26%
-4.07 %-107.10%
57.37 %-32.16%
84.58 %-8.06%
91.99 %+354.63%
20.23 %-59.69%
50.19 %+3,381.67%
1.44 %-98.06%
74.27 %+125.76%
32.90 %-54.94%
73.02 %-111.93%
-612.25 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Axe Compute Stock analysis

What does Axe Compute do? Predictive Oncology, Inc. generates revenue through its subsidiaries Helomics Holding Corporation and Skyline Medical Inc. Helomics applies artificial intelligence to patient tumor data to personalize cancer therapies and develop new-targeted therapies, offering CLIA-certified clinical testing for oncologists. Skyline Medical Inc. markets the STREAMWAY System, which automates medical fluid disposal, targeting hospitals and clinics globally. The company's products serve healthcare providers seeking advanced diagnostic and waste management solutions. Helomics focuses on personalized cancer treatment decisions using AI-driven analysis, while Skyline Medical Inc. provides automated fluid disposal systems. The STREAMWAY System is sold through domestic and international divisions to medical facilities requiring efficient waste handling. TumorGenesis Inc. supports laboratory-based tumor research, complementing Helomics' clinical offerings. The company's revenue streams include AI-based therapy personalization services and the STREAMWAY System sales. Healthcare providers, including oncologists and medical facilities, purchase these products to enhance treatment precision and operational efficiency. Subsidiaries operate under the parent company's structure, with Helomics handling AI applications and Skyline Medical managing medical device distribution. Axe Compute is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Axe Compute stock

Equity Ratio of Axe Compute is 90.22 % in 2025.

Equity Ratio of Axe Compute changed from -4.07 % to 90.22 %, representing a -2,314.26% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Equity Ratio Axe Compute since 2006 – with annual values, charts, and detailed analysis.

The equity ratio measures the proportion of total assets financed by shareholders' equity. Higher ratios indicate stronger financial independence and lower leverage.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Equity Ratio's Axe Compute with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Axe Compute

All Key Metrics — Axe Compute